Tower Research Capital (TRC)’s LAVA Therapeutics LVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,460
Closed -$18.1K 6034
2023
Q4
$18.1K Sell
11,460
-500
-4% -$790 ﹤0.01% 3712
2023
Q3
$17.6K Hold
11,960
﹤0.01% 3494
2023
Q2
$24.3K Buy
+11,960
New +$24.3K ﹤0.01% 3188
2021
Q3
Sell
-557
Closed -$6K 5993
2021
Q2
$6K Buy
+557
New +$6K ﹤0.01% 4633